skip to main content
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
previous page 1 Results 2 3 4 5 next page
Show only
Refined by: collection: Nature Journals remove
Result Number Material Type Add to My Shelf Action Record Details and Options
11
Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors
Material Type:
Article
Add to e-Shelf

Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors

CHEN, D.-F ; PRASAD, V. K ; LONG, G. D ; YANG, Y ; CHAO, N. J ; RIZZIERI, D. A ; BROADWATER, G ; REINSMOEN, N. L ; DEOLIVEIRA, A ; CLARK, A ; SULLIVAN, K. M ; CHUTE, J. P ; HORWITZ, M. E ; GASPARETTO, C

Bone marrow transplantation (Basingstoke), 2012-06, Vol.47 (6), p.817-823 [Peer Reviewed Journal]

Basingstoke: Nature Publishing Group

Full text available

12
Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis
Material Type:
Article
Add to e-Shelf

Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis

Liu, T ; Kishton, R J ; Macintyre, A N ; Gerriets, V A ; Xiang, H ; Liu, X ; Abel, E D ; Rizzieri, D ; Locasale, J W ; Rathmell, J C

Cell death & disease, 2014-10, Vol.5 (10), p.e1470-e1470 [Peer Reviewed Journal]

England: Springer Nature B.V

Full text available

13
Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection
Material Type:
Article
Add to e-Shelf

Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection

BYRNE, B. J ; HORWITZ, M ; LONG, G. D ; GASPARETTO, C ; SULLIVAN, K. M ; CHUTE, J ; CHAO, N. J ; RIZZIERI, D. A

Bone marrow transplantation (Basingstoke), 2008-01, Vol.41 (1), p.39-43 [Peer Reviewed Journal]

Basingstoke: Nature Publishing Group

Full text available

14
Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR
Material Type:
Article
Add to e-Shelf

Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR

Wieduwilt, Matthew J ; Stock, Wendy ; Advani, Anjali ; Luger, Selina ; Larson, Richard A ; Tallman, Martin ; Appelbaum, Frederick ; Zhang, Mei-Jie ; Bo-Subait, Khalid ; Wang, Hai-Lin ; Bhatt, Vijaya Raj ; Dholaria, Bhagirathbhai ; Eapen, Mary ; Hamadani, Mehdi ; Jamy, Omer ; Prestidge, Tim ; Pulsipher, Michael ; Ritchie, David ; Rizzieri, David ; Sharma, Akshay ; Barba, Pere ; Sandmaier, Brenda M ; de Lima, Marcos ; Kebriaei, Partow ; Litzow, Mark ; Saber, Wael ; Weisdorf, Daniel

Leukemia, 2021-07, Vol.35 (7), p.2076-2085 [Peer Reviewed Journal]

England: Nature Publishing Group

Full text available

15
Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplant
Material Type:
Article
Add to e-Shelf

Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplant

Pabon, Cindy M ; Li, Zhiguo ; Hennig, Therese ; de Castro, Carlos ; Neff, Jadee L ; Horwitz, Mitchell E ; LeBlanc, Thomas W ; Long, Gwynn D ; Lopez, Richard D ; Sung, Anthony D ; Chao, Nelson ; Gasparetto, Cristina ; Sarantopoulos, Stefanie ; Adams, Donna B ; Erba, Harry ; Rizzieri, David A

Blood cancer journal (New York), 2021-05, Vol.11 (5), p.92-92, Article 92 [Peer Reviewed Journal]

United States: Springer Nature B.V

Full text available

16
Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia
Material Type:
Article
Add to e-Shelf

Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia

WEINBERG, J. B ; VOLKHEIMER, A. D ; RIZZIERI, D. A ; LEVESQUE, M. C ; DEKROON, R ; STRITTMATTER, W. J ; MIHOVILOVIC, M ; JIANG, N ; CHEN, Y ; BOND, K ; MOORE, J. O ; GOCKERMAN, J. P ; DIEHL, L. F ; DE CASTRO, C. M

Leukemia, 2008-12, Vol.22 (12), p.2184-2192 [Peer Reviewed Journal]

Avenel, NJ: Nature Publishing Group

Full text available

17
A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML
Material Type:
Article
Add to e-Shelf

A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML

Garcia-Manero, Guillermo ; Podoltsev, Nikolai A ; Othus, Megan ; Pagel, John M ; Radich, Jerald P ; Fang, Min ; Rizzieri, David A ; Marcucci, Guido ; Strickland, Stephen A ; Litzow, Mark R ; Savoie, M Lynn ; Medeiros, Bruno C ; Sekeres, Mikkael A ; Lin, Tara L ; Uy, Geoffrey L ; Powell, Bayard L ; Kolitz, Jonathan E ; Larson, Richard A ; Stone, Richard M ; Claxton, David ; Essell, James ; Luger, Selina M ; Mohan, Sanjay R ; Moseley, Anna ; Appelbaum, Frederick R ; Erba, Harry P

Leukemia, 2024-01, Vol.38 (1), p.58-66 [Peer Reviewed Journal]

England: Nature Publishing Group

Full text available

18
Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma
Material Type:
Article
Add to e-Shelf

Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma

Sivaraj, Dharshan ; Green, Michael M ; Kang, Yubin ; Long, Gwynn D ; Rizzieri, David A ; Li, Zhiguo ; Garrett, Anderson H ; McIntyre, Jackie L ; Chao, Nelson J ; Gasparetto, Cristina

Blood cancer journal (New York), 2018-07, Vol.8 (8), p.71-4, Article 71 [Peer Reviewed Journal]

United States: Springer Nature B.V

Full text available

19
Response and toxicity of donor lymphocyte infusions following T-cell depleted non-myeloablative allogeneic hematopoietic SCT from 3-6 6 HLA matched donors
Material Type:
Article
Add to e-Shelf

Response and toxicity of donor lymphocyte infusions following T-cell depleted non-myeloablative allogeneic hematopoietic SCT from 3-6 6 HLA matched donors

RIZZIERI, Da ; DEV, P ; LONG, G. D ; GASPARETTO, C ; SULLIVAN, K. M ; HORWITZ, M. I ; CHUTE, J ; CHAO, N. J

Bone marrow transplantation (Basingstoke), 2009-02, Vol.43 (4), p.327-333 [Peer Reviewed Journal]

Basingstoke: Nature Publishing Group

Full text available

20
Cognitive impairment in candidates for allogeneic hematopoietic stem cell transplantation
Material Type:
Article
Add to e-Shelf

Cognitive impairment in candidates for allogeneic hematopoietic stem cell transplantation

Smith, Patrick J ; Lew, Meagan ; Lowder, Yen ; Romero, Kristi ; Thompson, Jillian C ; Bohannon, Lauren ; Pittman, Alyssa ; Artica, Alexandra ; Ramalingam, Sendhilnathan ; Choi, Taewoong ; Gasparetto, Cristina ; Horwitz, Mitchell ; Long, Gwynn ; Lopez, Richard ; Rizzieri, David ; Sarantopoulos, Stefanie ; Sullivan, Keith ; Chao, Nelson ; Sung, Anthony D

Bone marrow transplantation (Basingstoke), 2022-01, Vol.57 (1), p.89-94 [Peer Reviewed Journal]

England: Nature Publishing Group

Full text available

previous page 1 Results 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (392)

Creation Date 

From To
  1. Before2002  (17)
  2. 2002To2006  (60)
  3. 2007To2011  (109)
  4. 2012To2017  (112)
  5. After 2017  (96)
  6. More options open sub menu

Searching Remote Databases, Please Wait

  • Searching for
  • inscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Show me what you have so far